Veradigm | MDRX - Operating Profit


Veradigm reported $-45.47M in Operating Profit for its fiscal quarter ending in December of 2022.





Operating Profit Change Date
Alcidion AUD 2.2M 1.76M Dec/2025
Ambu A/S DKK 173M 9M Mar/2026
Amplifon EUR 79.86M 25.61M Jun/2026
Cardinal Health USD 861M 98M Mar/2026
Centene USD -43.18B 45.04B Jun/2026
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Cigna USD 2.76B 204M Mar/2026
Coloplast 1.85B 102M Dec/2025
Convatec Group USD 175.7M 101.1M Dec/2024
CVS Health USD 4.68B 2.57B Mar/2026
Diasorin EUR 56M 8.57M Mar/2026
Elevance Health USD 2.3B 8.11B Jun/2026
General Electric Aerospace USD 2.32B 549M Mar/2026
Gulf Medical Proj AED 25.67M 5.13M Mar/2026
Humana USD 1.36B 394M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Laboratory Of America USD 456.7M 46.6M Jun/2026
Maximus USD 148.49M 2.28M Mar/2026
McKesson USD 1.84B 181M Mar/2026
Med Life RON 43.91M 3.82M Mar/2026
Molina Healthcare USD 157M 19M Jun/2026
Omnicell USD 36.32M 19.28M Jun/2026
Oriola-kd EUR 4.4M 1000K Mar/2026
Owens Minor USD 814K 28.08M Dec/2025
Quest Diagnostics USD 459M 60M Jun/2026
Rede D'or Sao Luiz BRL 2.91B 350.85M Mar/2026
Siemens Healthineers EUR 947M 221M Jun/2026
Sonova Holding CHF 296.8M 156.9M Dec/2025
Supermax Corporation Bhd MYR -40.85M 22.71M Mar/2026
UnitedHealth USD 7.99B 1.05B Jun/2026
Veeva Systems USD 273.11M 27.24M Mar/2026
Veradigm USD -45.47M 70.47M Dec/2022
Xerox USD 30M 48M Jun/2025